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A B S TR A C T
Posttranslational modification by the Small Ubiquitin-like Modifier (SUMO) is a
pervasive mechanism for controlling protein function. SUMO is conserved from
yeast to man and is fundamental to eukaryotic life. Sumoylation is a dynamic
process and regulation of SUMO conjugate levels is accomplished in two ways.
First, SUMO can be removed from conjugate proteins by SUMO specific
proteases. In budding yeast Saccharomyces cerevisiae, the SUMO protease
Ulp1 is responsible for removing SUMO from target proteins and processing
SUMO precursor peptides. Ulp1 is essential for cell cycle progression;
however, few specific Ulp1 substrates have been identified. The first part of this
thesis utilized a substrate-trapping mutant of Ulp1, known as the U-Tag, to
identify candidate Ulp1 substrates. Our analysis has identified 32 candidate
Ulp1 substrates includingBm hl, a regulatory molecule that interacts with the
Anaphase Promoting Complex (APC). Bmh1 is a 14-3-3 protein that associates
with an APC component and was previously shown to be sumoylated. These
findings suggest a mechanism by which a SUMO protease can contribute to
cell cycle regulation. The second method cells use to regulate SUMO
conjugate levels is by destruction of sumoylated proteins in the ubiquitin
proteasome system. Recent work has identified a novel class of SUMOTargeted Ubiquitin Ligases (STUbLs) which selectively
ubiquitylatepolysumoylated proteins. In yeast, the STUbL heterodimer Slx5Slx8 has an important role in SUMO-targeted degradation. Slx5 is the targeting
domain of the STUbL complex and it usually resides in the nucleus where it
plays a key role in genome stability and DNA damage repair. Continuing work
in the lab has identified a physical interaction between Slx5 and the E3 SUMO
ligase known as Siz1. The data herein describes the functional consequences
of this interaction and demonstrates that slx5A cells accumulate sumoylated
and phosphorylated Siz1. These data suggestthat three different modifications
are involved in Siz1 regulation (SUMO, ubiquitin, and phosphorylation). Finally,
our data indicate that Siz1 is degraded in an Slx5 dependent manner when
nuclear export is blocked during G2/M. In summary, part two of this thesis
identifies targeting and localization domains in Slx5 and additionally provides
evidence that STUbLs may regulate levels of an E3 SUMO ligase.
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Chapter 1. Introduction
Posttranslational modification
Eukaryotic cells enhance the diversity of their proteome through the
covalent addition of chemical groups or peptides. For example, methyl groups,
acetyl groups, nitrosyl compounds, carbohydrates, lipids, or small proteins can
become covalently linked to the side chain of specific amino acids in a process
known as posttranslational modification. It is estimated that over 5% of the
proteome is dedicated to facilitating more than 200 types of posttranslational
modification (Walsh, 2006).
Posttranslational modification can modulate protein function in response to
internal cellular cues or external stimuli. The most common posttranslational
modification is phosphorylation. Mediated by a group of enzymes called kinases,
phosphorylation links an inorganic phosphate group donated by ATP to the side
chain of specific amino acids; most commonly serine, threonine, and tyrosine. A
phosphate group increases the local negative charge of residues to which they
are linked. Changes in protein charge profile can induce changes in conformation
or interactions which, in turn, modify protein function. One well studied example
is receptor signaling carried out by members of the mitogen activated protein
kinase (MAPK) family. MAPKs are well known for transmitting information across
the plasma membrane and into the nucleus using a trio of kinases acting
sequentially to begin a signal cascade. Phosphorylation is a reversible process
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and removal of phosphate molecules is facilitated by a group of enzymes called
phosphatases. In humans, there are more than 500 known kinases and over 150
phosphatases (Lothrop, Torres, & Fuchs, 2013; Walsh, 2006)
This thesis will focus on modification by two types of small peptide
modifiers; SUMO and ubiquitin. Sumoylation and ubiquitylation are discussed in
detail below.
Ubiquitin
One form of posttranslational modification that is widely used by
eukaryotic cells is the attachment of small proteins to the side chains of specific
residues such as lysine. The first protein modifier discovered, described in 1975,
is a 76 residue peptide known as ubiquitin which was named for its ubiquitous
distribution throughout the eukaryotic domain (Goldstein et al. 1975). Initially
discovered as a means to target proteins for proteasomal degradation,
ubiquitylation is now also known to regulate protein interactions, localization and
activity (Jackson & Durocher 2013). In yeast, ubiquitin is expressed as a
polyubiquitin fusion that must be processed by deubiquitylating enzymes (DUBs)
into conjugation competent monomers (Finley et al. 2012; Ozkaynak et al. 1984).
Attachment of ubiquitin to target proteins is an energy dependent process
carried out by a three enzyme cascade consisting of an E1 activating enzyme,
and E2 conjugating enzyme and an E3 ligase (model 1). Ubiquitylation is
reversible and processing of ubiquitin fusion protein is carried out by
deubiquitylating enzymes (DUBs) (model 1). Ubiquitin is the founding member of
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a conserved family of modifiers named ubiquitin-like proteins (Ubls). This family
contains at least 10 proteins which are all modestly related in sequence but, in
some cases, share a common three-dimensional structure (Kerscher et al. 2006).
SUMO
A second posttranslational modifier, known as SUMO, shares about 18%
sequence identity with ubiquitin. There are three SUMO isoforms in humans but
only one in yeast, Smt3. In this thesis, Smt3 will be refered to as yeast SUMO;
the yeast version of this posttranslational modifier. SUMO is a 110-amino acid
protein, and the second most widely characterized member of the Ubl family. It is
highly conserved among eukaryotes and essential for life (Johnson,
2004).Sumoylation has been shown to play a key role in facilitating DNA repair,
cell cycle progression, protein stability, transcription, and the stress response
(Kerscher et al. 2006). However, it also holds important roles in the assembly of
protein complexes.
SUMO processing and attachment
Initially, SUMO is expressed as a precursor that must be processed by a
SUMO protease into its conjugation competent form. Processing in yeast
involves the removal of three C-terminal residues by the SUMO-specific protease
Ulp1. This cleavage makes SUMO conjugation competent by exposing a di
glycine repeat that is the site of substrate attachment. After processing,
attachment is carried out by a three enzyme cascade reminiscent of the ubiquitin
system described earlier(model 1). To initiate substrate modification, SUMO
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must first be activated by an E1 activating enzyme which in yeast is a
heterodimer consisting of Aos1 and Uba2. The E1 uses ATP to form a high
energy thioester bond between the terminal glycine carboxylate and a catalytic
cysteine residue of the enzyme. This high energy bond is then transferred to a
catalytic cysteine residue on an E2 conjugating enzyme known as Ubc9. Finally,
Ubc9 transfers the SUMO to a lysine side chain on its target protein, with the
help of an E3 SUMO ligase that facilitates the conjugation onto specific proteins.
Conjugation usually occurs within the consensus sequence qj-K-x-D/E where qj is
hydrophobic, K is the lysine conjugated to SUMO, x is any amino acid, and D/E is
an acidic residue (Kerscher et al. 2006).Single SUMO molecules can be attached
to the same protein, or chains can form on residues within the tertiary structure of
SUMO monomers.
Of particular interest are four SUMO ligases in yeast; Siz1, Siz2, Mms21,
and the meiotic-specific Zip3. All four are members of the Siz/PIAS-RING (SP
RING) ligase family that shares sequence similarity to ubiquitin’s Really
interesting New Gene (RING) ligase family and function in a similar manner
(Johnson &Gupta 2001; Takahashi et al. 2001; Zhao & Blobel 2005; Cheng et al.
2006). SUMO ligases recruit SUMO charged E2 enzymes into a complex with the
substrate to facilitate conjugation. Although the SUMO E2 enzyme can catalyze
sumoylation alone, SUMO E3 ligases enhance conjugation to specific substrates
and deletions of Siz1 and Siz2 are non-lethal but have been linked to growth
defects and sensitivity to environmental stress. Siz1 and Siz2 are responsible for
over 90% of global sumoylation and they show considerable substrate overlap
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(Chen et al. 2011; Silver et al. 2011). There are, however, substrates specific to
either Siz1 or Siz2. For example, Siz1 is required for sumoylation of the septin
proteins Cdc3, Cdc11 and Shs1 (Johnson & Blobel, 1999).
SUMO removal
The covalent attachment of SUMO to specific substrates or other SUMO
proteins is a reversible process. SUMO can be removed from its substrates by
the same SUMO protease that renders it conjugation competent, Ulp1. This
protease cleaves the isopeptide bond between the SUMO carboxy-terminal
glycine and the lysine side chain to which it is linked. Cleavagereleases SUMO
monomer and the target protein in its initial conformation. A second SUMO
protease in yeast is called Ulp2. Ulp1 and Ulp2, have overlapping but non
identical substrates specificities but only Ulp1 can process the SUMO precursor
(Hickey et al. 2012). Both are cysteine proteases that contain a papain-like fold
and operate using a conserved -200 residue core domain (Ulp1 domain, or UD)
that houses a catalytic cysteine residue. Ulp1 is necessary for viability owing to
its ability to process precursor SUMO (Li & Hochstrasser 1999; Li & Hochstrasser
2000; Strunnikov et al. 2001). Ulp2 is non-essential but contributesto
chromosome stability owing to its involvement in recombination repair,
centromere cohesion and spindle formation (Lee et al. 2011; Schwartz et al.
2007; Baldwin et al. 2009). A third potential SUMO protease has recently been
uncovered. The metalloprotease known as Wss1 displays weak SUMOdependent isopeptidase activity in vitro. Interestingly, Wss1 also has
deubiquitylating activity and shows a preference for cleaving ubiquitin from
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SUMO chains. This activity, along with a newly discovered physical interaction
with the proteasome, have suggested that Wss1 acts on sumoylated substrates
entering the proteasome (Mullen, Chen, and Brill 2010).
Loss of Ulp1 mediated deconjugation results in cells arresting with large
buds, presumably late in the cell division cycle (Li & Hochstrasser 1999; Hickey
et al. 2012). Conversely, loss of Ulp2 is tolerated, but cells display sensitivity
towards DNA damage and heat stress along with defects in meiosis (Hickey et al.
2012). Additionally, cells expressing a temperature-sensitive mutant of Ulp1 build
up Clb2, a B-type cyclin that promotes the transition from G2 to M phase and is
targeted for destruction after mitosis(Kerscher, O.; unpublished observation). To
date, no substrates of Ulp1 involved in cell cycle progression have been
identified.
Roles for SUMO
Sumoylation plays diverse roles in a wide range of cellular functions. In
broad terms, attachment of SUMO may do one of three things. Firstly,
sumoylation can obscure interaction domains of its conjugate and act as an
antagonist to other substrates binding. For example, in yeast, the proliferating
cell nuclear antigen (PCNA) undergoes sumoylation during S-phase. This
sumoylation event occurs predominantly on lysine 164; a residue which can
undergo both mono- and poly-ubiquitylation as well. Sumoylation on K164
obscures the residue from the ubiquitylation machinery and, in doing so, prevents
PCNA-dependent DNA repair (Pfander et al. 2005; Hoege et al. 2002). Secondly,
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sumoylation can lead to conformational changes in conjugate proteins, exposing
or hiding key interaction domains within the target. For example, in humans,
thymine DNA glycosylase (TDG) initiates base excision repair by removing
thymine from sites of nucleotide mismatch, generating an abasic site. SUMO
conjugation to TDG induces a conformational change which promotes TDG
dissociation from the abasic site (Steinacher & Schar 2005; Baba et al. 2005).
Thirdly, sumoylation can recruit interacting partners to conjugate protein.
Recruitment of novel interacting partners can be done by creation of a new
interaction domain at the SUMO interface or by direct non-covalent interactions
with attached SUMO. As an example, the yeast SUMO-Targeted Ubiquitin Ligase
(STUbL) complex Rad18 interacts specifically with sumoylated PCNA using
SUMO-interacting motifs (SIMs) near the amino-terminus of the ligase. This
SUMO facilitated interaction stimulates mono-ubiquitylation of PCNA in response
to DNA damage (Parker & Ulrich 2012). Sumoylation is required for viability and
changes made to a protein by sumoylation have broad biological importance. To
date, the yeast SUMO proteome consists of more than 500 proteins effecting 15
major biological pathways (Tan et al. 2013). However, the function of only a
handful of sumoylated proteins is known.
Chains of SUMO and Ubiquitin
One hallmark of modification by SUMO and ubiquitin is the ability of these
Ubls to form chains. Both SUMO and ubiquitin present internal lysine residues
that can be used to assemble polymeric chains. Poly-modifier chains can be
linear when linked to the same residue uniformly, or branched chains can form
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when multiple lysines are used. Assembly and disassembly of chains are carried
out using the same enzymatic machinery as single-moiety modification (model
1previewed by Ulrich 2008; Kerscher et al. 2006)
For ubiquitin, seven internal lysines as well as the N-terminus are targets
for polyubiquitylation(Finley et al. 2012). The most prominent function of
polyubiquitylation is the initiation of protein degradation; polyubiquitylation by K48
linked ubiquitin chains directs conjugated proteins to the proteasome (Chau et al.
1989). Research into the roles of ubiquitin chain formation is ongoing, but distinct
outcomes for polyubiquitylation have been identified. For example,
polyubiquitylation by K63 linked ubiquitin chains activates kinases in the NF-kB
pathway leading to NF-kB activation (Chen 2005). Ubiquitin is an information rich
molecule, and construction of distinct chains results in a “ubiquitin code”; a
structure of ubiquitin molecules readable by a large family of ubiquitin receptors
(Finley et al. 2012; Randles & Walters 2012).
In contrast to ubiquitin chains, relatively little is known about the function
of poly-sumoylation. Yeast SUMO contains consensus SUMO attachment sites
at K11, K15, and K19 which act as acceptors for SUMO polymerization (Ulrich
2008). Current reasoning suggests that poly-sumoylation creates additional
binding surfaces on the modified target allowing for more robust non-covalent
interactions of an effector protein containing SUMO-interacting motifs (SIMs)
(Ulrich 2008). For example, the promyelocytic leukemia protein (PML) is a polysumoylated protein which also contains a SIM in its C-terminus. Poly-sumoylation
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of PML promotes nucleation of PML and assembly into nuclear bodies (NBs)
through SUMO-SIM interactions (Kerscher 2007; Gao et al. 2008).
SUMO-mediated interactions
SIMs arenoncovalent SUMO-binding elements within SUMO-interacting
proteins. SIMs allow SIM-containing proteins to interact with their sumoylated
binding partners. One SIM has been described so far which has a loose core
consensus motif (V/l-X-V/l-V/l) (Song et al. 2004). This hydrophobic core takes
on an extended conformation that embeds within a hydrophobic surface
depression of SUMO. Flanking acidic residues can orient the binding of SIM to
SUMO (Kerscher 2007; Hochstrasser 2009). Additionally, phosphorylation
juxtaposed to the hydrophobic core can increase the number of charges and
facilitate SUMO interaction (Stehmeier & Muller 2009).
Historically, SUMO has been proposed to antagonize ubiquitin conjugation
on common substrates (Desterro et al. 1998). Recent evidence, however,
revealed cross-talk between the ubiquitin and SUMO systems. Evidence is
accumulating that SUMO chains can be sequentially modified by ubiquitin,
forming hybrid SUMO-ubiquitin (ub) chains(Mullen & Brill 2008; Sun et al. 2007;
Guzzo et al. 2012). Construction of these hybrid SUMO-ub chains is carried out
by a newly defined group of enzymes known as SUMO-Targeted Ubiquitin
Ligases (STUbLs) (Mullen & Brill 2008; Xie et al. 2007). STUbLs mediate hybrid
chains’ function to direct modified proteins to the proteome and have been
suggested to play a role in genome stability, transcriptional regulation, and DNA
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stability (reviewed by Wang & Prelich 2009; Heideker et al. 2009). Adding to the
complexity, emerging research has identified enzymes that recognize hybrid
chains using a tandem SUMO- and Ubiquitin (tSIM-UlM) interacting motif (Guzzo
& Matunis 2013). Tandem SIM-UIM containing proteins act on substrates
previously targeted by STUbLs. For example, the BRCA1 -A subunit RAP80 is a
DNA repair factor and the first described tSIM-UlM containing protein. RAP80
interacts with ~80-fold higher affinity to hybrid SUMO-Ub chains in comparison to
monomorphic SUMO or ubiquitin chains (Guzzo et al. 2012).
SUMO-Tarqeted Ubiquitin Ligases
STUbLs have been identified in multiple organisms and the STUbL family
currently consists of: Human RNF4; Schizosaccharomycespombe Rfp1, Rfp2
and Slx8; Dictyosteliumdiscoideum Mip1; Drosophila me/anogasterdegringolade;
and Saccharomyces cerevisiae Slx5-Slx8, Rad18, and potentially Uls1 (Sun et al.
2007; Parker & Ulrich 2012; Denuc & Marfany 2010; Alonso et al. 2012). To date,
all known STUbLs share an N-terminal SUMO recognition region (with multiple
SIMs) used in target identification as well as a C-terminal RING finger domain
(Denuc & Marfany 2010). STUbLs are evolutionary conserved and
STUbLorthologs from other species can complement yeast STUbL mutants
(Kosoy et al. 2007; Sun et al. 2007; Prudden et al. 2007). The best characterized
members of the STUbL family are human RNF4 and budding yeast Slx5-Slx8.
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Slx5-Slx8: A Yeast SUMO-Tarqeted Ubiquitin Ligase
Slx5 is one of the founding members of the STUbL class of enzymes.
Originally identified in a synthetic lethal screen of cells lacking Sgs1, it functions
as a heterodimer with Slx8 harboring RING-dependent ligase activity, and SIM
containing Slx5 primarily responsible for SUMO recognition (Mullen et al. 2001).
Slx5-Slx8 controls the levels of cellular sumoylated proteins and highmolecular weight SUMO chains and is required for genome stability and DNA
damage response (Uzunova et al. 2007; Zhang et al. 2006; Xie et al. 2007). Slx5
and Slx8 reside in the nucleus and Slx5 also forms distinct foci and localizes to
sites of double stranded DNA breaks (Cook et al. 2009; Nagai et al. 2008). Loss
of Slx5-Slx8 function leads to gross chromosomal rearrangements, spontaneous
DNA damage, and sensitivity to genotoxic stress (Nagai et al. 2011; Heideker et
al. 2009). Slx5-Slx8 appears to direct SUMO-conjugated proteins to the
proteasome by mediating ubiquitylation (Uzunova et al. 2007; Mullen & Brill
2008). Consistent with this role, overexpression of Slx5 (in the presence of
conjugation-competent SUMO) suppresses the lethality of u lp lts cells (Xie et al.
2007).
Known substrates of Slx5-Slx8 include the transcriptional regulator Mot1,
which regulates the DNA binding ability of TATA-binding protein, as well as the
mating type transcription co-activators MATal and MATa2 that regulate
transcription from mating type-specific genes (Wang & Prelich 2009; Xie et al.
2010; Nixon et al. 2010). Few In vivo targets of Slx5-Slx8 have been identified to
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date largely due to the difficulty in identifying E3 targets. The small overall
population of sumoylated proteins and the transient nature of ubiquitylated
proteins hamper substrate identification. Previous work in the Kerscher lab has
identified the E3 SUMO ligase known as Siz1 to be a potential target for the Slx5Slx8 complex. Yeast two-hybrid assays performed in the Kerscher lab by
previous master’s student Jason Westerbeckdemonstrated a robust interaction
between Siz1 and Slx5. Furthermore, Westerbeck and colleagues found that the
interaction between Siz1 and Slx5 may be SUMO-dependent and requires a SIM
located in the N-terminal domain of Slx5. They went on to show that Siz1 is an in
vitro ubiquitylation substrate of Slx5-Slx8 (Westerbeck et al. 2013).
Aims
We hypothesize that Ulp1 desumoylates a key cell cycle regulator and
loss of Ulp1 activity stalls the cell cycle during G2/M phase. Chapter 2 of this
thesis describes the use of a novel substrate trapping mutant of Ulp1 created in
the Kerscher lab by former master’s student Zac Elmore to identify and
functionally characterize Ulp1 substrates involved in cell cycle progression
(Elmore et al. 2011).
Chapter 3 of this thesis builds on previous data described aboveand will
investigate the functional interplaybetween Siz1 with Slx5. Specifically,chapter 3
will show that Slx5 affects the steady state level of Siz1. Additionally, it will
demonstrate that Slx5 affects the phosphorylation and sumoylation status of Siz1
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and will investigate the localization of GFP-tagged Siz1 in WT cells in
comparison to slx5A, msn5A, and slx5A/msn5A mutant strains.

S U M O /U b Precursor

Processing

DUB o rU lp

Deconjugation
Substrate

^

Substrate
DUB o rU lp

Substrate

El, E2, E3

Conjugation
E l + ATP

E3

Activating Enzyme

Ligase

Conjugating Enzyme

Model 1. The ubiquitin and SUMO cycles. Precursor SUMO and ubiquitin (blue
rectangle) are initially processed by DUB/Ulp isopeptidases into conjugation
competent form. Once processed, the modifier is covalently conjugated to a lysine
side chain of a targeted substrate (red oval) in a three enzyme cascade consisting
of E1 activating enzyme (light blue), E2 conjugating enzyme (green) and E3 ligase
(yellow). After conjugation, additional monomers can be added to the substrate, or
the process can be reversed by removing the modification using a DUB or Ulp
isopeptidase (Kerscher et al. 2006).
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Chapter2. A substrate trapping mutant of Ulp1 for the identification of
SUMO protease targets

Elmore et al. (2011) have previously reported the ability of a
mutated form of Ulp1 to act as a substrate-trapping mutant. In their work, a
truncation of Ulp1 comprising only the catalytic region (region 3) of the protein (Li
& Hochstrasser 2003) was mutated by site directed mutagenesis. By switching
the active cysteine residue at position 580 to a serine, the authors’ generated a
substrate-trapping mutant designated Ulp1(lll)C580S.
In this chapter we utilized the substrate-trapping mutant of U lp l’s catalytic
domain, Ulp1(HI)C580S, to affinity purify and selectively enrich SUMO protease
substrates. We identified 32 candid Ulp1 substrates through mass spectrometry
analysis of U-Tag purified proteins.

Materials and Methods
Yeast strain, plasmids, bacteria and growth conditions
Yeast, plasmids, and bacterial strains used for this work are listed in table
1. Yeast media preparation and growth conditions were carried out as previously
described (Amberg et al. 2005). All yeast strains were grown at 30°C in 2x media
unless noted otherwise. Cells expressing a temperature-sensitive mutant of Ulp1
(u lp lts ) contain three mutations (1435V, N450S and I504T) in the catalytic
domain, region 3 (Li & Hochstrasser 1999).
Recombinant protein expression and bacterial protein extraction
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Induction of U-Tag overexpression - BOK 752 containing maltose binding
protein fused Ulp1 (lll)C580S(Elmore et al. 2011) was inoculated into 4mL of LB
broth containing 60pg/mL carbenicillin (USABiological) and cultured overnight,
rotating at 37°C. This 4mL culture was added to 200mL of SOC and grown at
37°C to OD6oo0.3-0.5. A 1mL sample was harvested, washed once in 1x PBS,
and resuspended in 1x LDS sample buffer containing 4% 2-mercaptoethanol
(BME) (Invitrogen). This sample was boiled at 110°C for 3 minutes and then
frozen at -80°C. This freeze then thaw process was done a total of three times.
To the remaining culture, 80pL of 1M IPTG was added to induce MBPUlp1 (|||)C580S expression. The culture was shaken for 5 hours at 18°C. Another
1mL sample was taken as described above. To analyze protein induction, 10pL
and 20pL of induced protein sample were subjected to SDS-PAGE on a pre-cast
4-12% Bis-Tris mini-gel (NuPAGE, Invitrogen). Samlples ran for 55 minutes at
200 volts in commercial MOPS buffer (Invitrogen). Bands were analyzed by
staining with Simply Blue SafeStain (Invitrogen) as per the manufacturer’s
instructions.
The induced culture was harvested at 4°C for 15 minutes at 2,320x g
(RCF). The supernatant was decanted away and residual media was removed by
pipetting. Cell pellets were kept on ice and resuspended in 4mL of phosphate
buffered saline (PBS) (10 mMphosphate, 150 mM sodium chloride, pH 7.4)
containing 1x Halt Protease Inhibitor (PI) Cocktail, EDTA free (Thermo Fisher
Scientific). These 4mL were spun down into a 2mL cryo-tube and snap frozen in
liquid nitrogen. Pellets were kept at -80°C until use.
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Bacterial protein extraction - Frozen induced cell pellets were thawed on
ice and resuspended in 800pL 1x PBS containing 1x PI. Total volume was
brought up to 2mL with 1x PBS. Cell suspensions were sonicated three times at
20% duty cycle for 20 seconds. Resulting lysates were clarified by centrifugation
at 20879 x g (RCF) for 8 minutes in a refrigerated centrifuge. The supernatant or
extracted protein was removed to a pre-chilled 15mL screw cap tube and the
volume was adjusted to 4mL total using cold 1x PBS.
Affinity resin preparation - Gravity filtration columns were assembled as
per the manufacturer’s instructions (Thermo Fisher Scientific). 500pL of amylose
resin suspension (New England Biolabs) was equilibrated in ice cold 1x PBS.
Then, equilibrated amylose resin was added to the column as a bed and washed
three times with cold 1x PBS. Bacterial protein extractions (previous section)
were added to the column to purify MBP tagged Ulp1 (lll)C580S. After three washes
in ice cold 1x PBS, amylose resin with bound MBP tagged Ulp1(lll)C580S was
removed from the column and stored on ice in 1mL of 1x PBS containing 0.02%
sodium azide. Amylose bound MBP-Ulp1 (|||)C580S is hereafter referred to as ‘UTag affinity resin.’
Yeast protein extraction
A single colony of YOK 428 was grown overnight in 40mL of selective
media containing 2% dextrose and 200pg/ml_ G418. The next day, the 40mL
starter culture was added to two liters of selective media containing 2% dextrose
giving an OD6oo of about 0.2. The two liter culture was split into four flasks for
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overnight growth. The third day, the logarithmically growing culture was diluted
1:2 in YPD to an OD6oo of 0.8 and allowed to grow an additional 3 hours. The
whole culture was harvested by centrifugation at 4,000xg for 10 minutes at 4°C.
The pellet was washed first in 50mL wash buffer (table 2; appendix) and then in
10mL of extrusion buffer (table 2; appendix). Residual buffer was removed by
micropipettor and the cell paste was scooped into a 10mL syringe with a sterile
spatula. The cells were then extruded from the syringe into a 50mL centrifuge
containing liquid nitrogen and snap-frozen as high density ‘noodles’ of cells.
Snap frozen cell noodles were added to a pre-cooled (-20°C) coffee
grinder (Biospec Products) containing pre-powdered dry ice (enough to cover
cells). The grinder was run for 5 minutes at -20°C to pulverize the cells. The
resulting powder was placed at -80°C until the remaining dry ice is sublimated.
Pulverized cell powder was resuspended in 20mL of extraction buffer + PI (table
2; appendix) then snap frozen.
U-Taq affinity chromatography
500pL of U-Tag affinity resin (preparation described above) was
equilibrated in extraction buffer by washing 3 times with 1ml_ each. Equilibrated
U-Tag resin was transferred to a gravity filtration column (Thermo Fisher
Scientific), washed two additional times with one column volume of extraction
buffer, and kept at 4°C.
Frozen yeast protein extract (described above) was thawed on ice. A 30pL
aliquot was taken, mixed with an equal volume of 2x LDS sample buffer + 8%
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BME (Invitrogen), and used as whole-cell extract in subsequent protein analysis
(supplemental figure 6). To the chilled affinity column, 7.5mL of yeast protein
extract was gravity filtered through the resin bed. The resin bed was then washed
with three column volumes of extraction buffer + PI (table 2; appendix) containing
1% triton x-100. The substrate-bound U-Tag resin was transferred to a
microcentrifuge tube and a 30pL sample was taken for subsequent protein
analysis.
Proteins bound to U-Tag affinity resin were eluted from the resin using
commercially available recombinant Ulp1-His6 (Invitrogen) to cleave captured
substrates from the U-Tag. Cleavage and purification were carried out as per the
manufacturer’s instructions. Briefly, substrate-bound U-Tag resin was collected
by gentle centrifugation (5 seconds, 60 x g(RCF)) and resuspended in 200pl of
the supplied 1x SUMO protease buffer. 10 units of SUMO protease were added.
The tube was mixed gently and the reaction was incubated at 30°C for 6 hours.
After incubation, the supernatant was collected and purified using a commercial
PrepEase (affymetrix) Histidine-Tagged protein purification kit to remove Ulp1His6. Column flow through containing SUMO conjugates and free SUMO were
used in subsequent protein analysis.
Silver stain and mass spectrometry
Protein concentration of the purified SUMO conjugates solution (above
section) was measure using commercial BCA assay kit (Sigma) as per the
manufacturer’s protocol. Then, 50ng of total protein were separated on a precast
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4-12% Bis-Tris mini-gel (NuPAGE, Invitrogen) for 55 minutes at 200 volts in 1x
MOPS buffer. Protein bands were visualized in the gel using a commercial Pierce
silver staining kit for mass spectrometry (Thermo Fisher Scientific) as per the
manufacturer’s instructions.
The remaining solution of purified SUMO conjugates (~150pg) was sent to
the Yale proteomics facility (Keck Biotechnology Resource Laboratory) for mass
spectrometry analysis.

Results
Considering the important role of SUMO deconjugation to SUMO
homeostasis, we sought to identify novel targets of Ulp1. Furthermore, given the
essential nature of Ulp1 to the cell cycle, we reasoned that one or more proteins
that co-purify with Ulp1(lll)C580Swould be Ulp1 targets that are critically important
for cell cycle progression. Here we report the use of Elmore and colleagues’
substrate-trapping mutant, known as U-Tag, to selectively purify Ulp1interactingproteins(Elmore et al. 2011).

U-Tag affinity purifies sumoylated proteins from whole cell extracts
Cellular extracts fromu lp lts mutantYOK428 were subjected to U-Tag
affinity purification (supplemental figure 6).Fifty nanogramsof purified protein and
an equal volume of mock purificationeluate were separated by SDS-PAGE and
visualized with silver stainingto identify protein bands. Several distinct bands
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were observed in the sample lane (figure 1. Lane 2) and were not present in the
mock column control lane(figure 1. Lane 3) suggesting that these bands are UTag co-purifying proteins. Notably, we identified asingle band at about 20kDa
consistent with monomeric SUMO that was liberated from its substrate by
recombinant Ulp1 (see methods; elution step). Several additional robust bands
representing U-Tag purified proteins are indicated by arrows in figure 1.

Mass spectrometry analysis identifies 32 U-Tag co-purifying proteins
In order to identifyU-Tag affinity purified proteins,mass spectrometry
analysis was carried out by the Yale Proteomics facility (W.M. Keck
Biotechnology Laboratory; New Haven, CT). Multiple dimension protein
identification technique (MudPIT) was used to identify and sequence 69 peptide
fragments belonging to 32 distinct proteins (table 3; appendix). Proteins
represented by multiple fragments were present in relatively high concentration.
Eight candidate sumoylated proteins were identified with more than three
fragments; BMH1, SMT3, EF2 (ETF2), HSP82, KPYK1 (CDC19), PHSG (GPH1),
RLAO (RPPO), and VATE (VMA4) [table3; parentheses represent gene names
from Saccharomyces Genome Database]. In table 4, we have highlighted BMH1,
VATE, and EF2 as candidates for future investigation as well as yeast SUMO
which is our internal control. Vma4, Ef2, and Bmh1 were all previously identified
as a sumoylated proteins in high-throughput proteomic studies (Denison et al.
2005; Sung et al. 2013). Bmh1 is of particular interest to us given the many
regulatory functions of 14-3-3 proteins and its association with the anaphase
promoting complex.
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In summary, our data confirm that the U-Tag can effectively purify and
enrich sumoylated proteins. Additionally, we have identified several candidate
Ulp1 substrates including one regulator of the anaphase promoting complex.
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Figure 1. U-Tag affinity resin selectively purifies sumoylated proteins from
cellular extracts. Sumoylated proteins from YOK 428 were U-Tag affinity purified
and eluted as described in Methods. 50ng of U-Tag purified proteins were loaded in
lane 2 and an equal volume of mock eluate in lane 3. Lane 1 contains a molecular
weight standard and lane 4 contains whole cell protein extraction (WCE) as a
control for protein separation. Input proteins were run on a 4-12% Bis-Tris gel and
Silver stained with Pierce silver staining kit for mass spectrometry (Thermo
Scientific). Arrows indicate positions of select bands present in U-Tag lane but not
in mock column control lane. Numbers indicate approximate molecular weight (left)
and lane designation (bottom).
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Discussion
This chapter reveals that the substrate-trapping mutant of UlpVs catalytic
domain, Ulp1(lll)C580S(Elmore et al. 2011), can be employed to affinity purify,
selectively enrich, and identify candidate Ulp1 substrates. One interesting
observation made from this screen for U-Tag interacting proteins is that Bmh1
carries the potential to be a Ulp1 substrate. Bmh1 is one of two proteins in
Saccharomyces cerevisiae that represent the highly conserved 14-3-3 family of
proteins. Previous proteomic studies have shown Bmh1 to be sumoylated
(Denison et al. 2005) and revealed many putative interacting partners. Recent
work in the Kerscher lab by Jeremy Wells (WM class of 2014) has confirmed
Bmh1 sumoylation biochemically in a molecular weight shift assay,but the exact
cellular consequences of Bmh1 sumoylation are unknown. Bmh1 has recently
been shown to be a regulator of the cell cycle (Dial et al. 2007). Bmh1, in
complex with the pseudosubstrate inhibitor Acm1, binds to a co-activator of the
Anaphase-promoting complex (APC) known as Cdh1. This interaction sequesters
Cdh1 and inactivates the APC; an event necessary for cell cycle progression
through S-phase (Dial et al. 2007).
We propose that SUMO may play a role in Bmh1 ’s cooperative regulation
of the APC and that interactions with Ulp1 regulate its sumoylation (model 2).
Specifically, we propose that sumoylation of Bmh1 facilitates the interaction
between Bmh1/Acm1/Cdh1 (CAB complex) and mediates APC deactivation at
the onset of S-phase. Furthermore, we hypothesize that Ulp1 mediates
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desumoylation of Bmh1 after G2, which initiates the dissociation of the CAB
complex and reactivates the APCCdh1. This hypothesis is supported by previous
findings that u lp lts cells grown at non-permissive temperatures arrest as large
budded cells, presumably late in the cell cycle. This late-stage arrest could be
caused by a failure of Ulp1 to desumoylate cell cycle regulators, such as Bmh1.
Additionally, strains expressing u lp lts have artificially stabilized Clb2 levels. Clb2
is a B-type cyclin and APC substrate that promotes transition from G2 to M
phase in yeast cells. Clb2 is targeted for destruction via a destruction box motif
during G1 when the CAB complex is dissociated and the APCcdh1 is active. This
buildup of Clb2 could be due to reduced APC activity and prolonged
sequestration of CDH1 in the CAB complex, potentially because Ulp1 fails to
desumoylate Bmh1.
To this end, our future work will investigate the consequences of Bmh1
sumoylation. Using a SUMO deficient mutant of Bmh1 Ulp1 created in the
Kerscher lab by Jeremy Wells (Bmh1 sumo-no-more or SMN; figure 2) we will
conduct a top-down investigation of the role of Bmh1-SUMO on the cell division
cycle. We will use a bmh1 Abmh2Adoub\e mutant strain expressing either wildtype Bmh1 or Bmh1 (SNM) from a plasmid to look for growth defects incurred
from loss of Bmh1 sumoylation. Preliminary experiments performed in the
Kerscher lab by Jeremy Wells have revealed a temperature sensitive phenotype
associated with deficient Bmh1 sumoylation.
Next, we will verify Bmh1-SUMO as a U-Tag interacting protein and a
Ulp1 substrate in vivo. By co-expressing affinity tagged Ulp1(lll)C580S and epitope
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tagged Bmh1 we will pull downUlp1(lll)C580S and co-purify sumoylated Bmh1 from
yeast extracts. From there, we will express tagged Bmh1 in aulp 1ts strain
coexpressing conjugation competent SUMO to show that desumoylation of Bmh1
is abolished at non-permissive temperatures.
Finally, we plan to investigate the molecular consequences of Bmh1
sumoylation. Again, using the SUMO-deficient mutant we will determine what, if
any, role sumoylation plays in the regulation of APC0dh1 activity. Specifically, we
will determine if CAB complex formation and dissociation is facilitated by Bmh1SUMO dynamics.
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Model 2. Proposed role fo r SUMO dynam ics in regulation o f APCCdh1 activity.
Sumoylation of Bmhl during late G1 (bottom arrow) facilitates the association of
Bm hl, Acm1, and the APC co-activator Cdh1 (CAB complex) (Dial et al. 2007).
Sequestration of Cdh1 in the CAB complex throughout S-phase and G2 maintains
the APC in an inactive state. Ulp1 mediated desumoylation of Bmhl in late G2 or
early M phase (top arrow) causes dissociation of the CAB complex and APCCdh1
reactivation. The APCCdh1 then triggers mitotic exit through degradation of the
cyclin Clb2.
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Chapter 3. A SUMO-targeted ubiquitin ligase is involved in the cell cyclespecific degradation of the SUMO E3 ligase Siz1

Chapter 3 builds on previous data collected by Jason Westerback
described above and reported in the Kerscher lab’s most recent publication
(Westerbeck 2011). This chapter reports our findings on the functional interplay
between Siz1 with Slx5. Specifically; the data presented here shows that Slx5
affects the steady state level of Siz1. Additionally, it demonstrates that Slx5
influences the phosphorylation and sumoylation status of Siz1. Finally, this
chapter reports the localization of GFP-tagged Siz1 in WT cells in comparison to
sfx5A, msn5A, and slx5A/msn5A mutant strains.

Materials and Methods
Yeast strains. Media and Plasmids
Yeast strains and plasmids used in this study are listed in Table 1.
Unless otherwise noted, yeast media preparation and manipulation of yeast
cells was performed as previously reported (Guthrie and Fink, 2002). All
strains were grown at 30°C unless otherwise noted.

Cell synchronization and drug treatments

Where indicated yeast cells were synchronized in G2/M phase by
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incubating logarithmically grown cells in 15 pg/ml nocodazole (Acros
Organics 358240500) for 3 hrs at 30°C. Cells were arrested in S-phase by
addition of 0.1 M hydroxyurea (Sigma H8627) and incubation at 30°C for 3
hours. For cycloheximide chase experiments, 25 pg/ml cycloheximide (Sigma
C7698) was added to G2/M arrested cells. 2.5 ODs of cells were harvested at
the indicated time-points.

Cloning and epitope-tagging of yeast genes

Chromosomal tagging and gene deletions in yeast were carried out by
PCR-based homologous recombination (Longtine etal., 1998). Strain
YOK821 (slx5A) was used to epitope tag SIZ1 with a 13myc epitope tag.
Briefly, primers OOK663 and OOK662 were used to amplify the 13xmycADH1-His3MX6 cassette with 40bp of SIZ1 sequence homology from the
plasmid pFA6a-13myc-His3MX6 (Longtine). PCR amplification was carried
out using Phusion High-Fidelity PCR kit (NEB E0553S) with DMSO and high
GC buffer as recommended by the manufacturer. For transformation, 6.5 pg
of purified SIZ1-13myc-His3MX6 PCR product was combined with 4 ODs of
competent s/x5A (YOK821) cells, incubated for 30 minutes at 30°C, heat
shocked at 42°C for 30 minutes and plated on SD-His dropout. Resulting
colonies were screened by western blotting using an anti-myc antibody.
Subsequently, the SIZ1-myc slx5A strain (YOK2264) was backcrossed to
YOK819 to obtain StZ1-myc SLX5(WT) progeny (YOK2286). An amplicon of
SIZ1-13myc was also cloned into a gateway compatible pRS315 plasmid.
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The msn5 null mutant was constructed in the Kerscher lab by Nagesh
Parsupala. who introduced a Hygromycin deletion cassette with 78 bp
flanking sequence homology to msn5 gene upstream and downstream
region.

Preparation of yeast extracts, gel electrophoresis, and western blotting

Whole cell yeast extracts were prepared by TCA glass bead lysis. Briefly,
- 4 ODs of pelleted yeast cells were washed once in 800 pi of 20% TCA and
resuspended in 400 pi of 20% TCA. 200 pi of glass beads (Sigma G8772)
were added and the samples were vortexed at 4°C for 4 minutes. The beads
were allowed to settle and the supernatant was transferred to a new tube and
pelleted by centrifugation at 15K rpm for 8 minutes.

Pellets were washed

once using 800 pi of ice-cold 2% TCA. The supernatant was removed and
pellets were resuspended in 200 pi of TCA-sample buffer (15% glycerol, 80
mM Tris base, 3.5% SDS, Bromophenol Blue, and BME [40 pl/ml]). The
samples were boiled at 100°C for 2 minutes, and whole cell protein extracts
corresponding to - 0.2 ODs were separated on a pre-cast NuPAGE Novex 412% Bis-Tris gels (NP0321 Life Technologies) or home-made 8% Tris-Glycine
gels. After separation proteins were transferred to polyvinylidene difluoride
(PVDF) membrane (IPVH00010 - Millipore) for 30 minutes at 19 V. Blots were
blocked in TBS (150 mM NaCI, 50 mM Tris-HCI at pH 7.4) containing 4% milk
for an hour and then incubated in 4% milk containing primary antibody
overnight at 4°C followed by incubation with secondary antibodies for 1-3
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hours at ambient temperature. After antibody incubations blots were
extensively washed in TBS + 0.1% Tween 20 (TBST). Antibodies were used at
the following concentrations; anti-myc (1:5000; Covance MMS-150R), antiPgk (1:10000; Life Technologies A6457), anti-mouse(HRP) (1:15,000; abeam
ab9740). Proteins were visualized on film using ECL substrate (Millipore
Immobilon Western ECL substrate WBKL SO 100).

Fluorescent Microscopy

Images of live cells were collected using a Zeiss Axioskop fitted with a
Retiga SRV camera (Q-imaging), i-Vision software (BioVision Technologies),
and a Uniblitz shutter assembly (Rochester, NY). Pertinent filter for the above
application

was

CZ909

(GFP)

(Chroma

Technology

Group).

Where

applicable, images were normalized using i-Vision software.

Results
Slx5 affects the steady-state level, phosphorylation, and sumoylation of
Siz1 in vivo
In order to understand the role of Slx5 in Siz1 stability, we compared
endogenous Siz1 levels from wild-type (WT) and slx5 null (A) strains. Briefly,
YOK 2264 containing 13X Myc-tagged Siz1 was mated with isogenic WT strain
YOK 819. In meiotic progeny expressing Myc-tagged Siz1, immuno-blotting
detected the protein running as a distinct band just below the 150kDa marker
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(Figure 3A). Intriguingly, an increased level of high molecular weight adducts of
Siz1 were also observed in slx5A cells. These slower moving abducts are
consistent with sumoylated forms Siz1.
Siz1 is located in the nucleus during interphase, but is exported to the
cytoplasm during mitosis. As mentioned above, cytosolic Siz1 enriches at the
bud neck of dividing yeast cells where it sumoylates the septin proteins Cdc3,
Cdc11, and Shs1 (Johnson and Gupta, 2001). Nuclear egress of Siz1 is
mediated by the karyopherin Msn5 which is known to export phosphorylated
proteins (Makhnevych et al., 2007). At a point prior to anaphase, Siz1 becomes
phosphorylated by an unknown kinase, which may be linked to its export by
Msn5 (Johnson and Gupta, 2001). We investigated the phosphorylation status of
Siz1 by comparing both W T and slx5A cells growing logarithmically, arrested in
S-phase with hydroxyurea (HU), and arrested in G2/M with nocodazole (N2)
(Figure 3B). The levels of unmodified Siz1 as well as two phosphorylated forms
were markedly enhanced in slx5A cells. The effect was less pronounced after Sphase and G2/M arrest with almost complete phosphorylation of Siz1 in G2/M
arrested cells. Phosphorylation was confirmed by phos-tag SDS-PAGE (Wako
Pure Chemical Industries) and immune-blotting (Parsupala, N., 2013; data not
shown).

Slx5 is required to modulate the levels of Siz1 in the nucleus during mitosis
As shown in Figure 3, Slx5 influences the steady state level of Siz1 by an
undetermined mechanism. This increase in steady state is coupled with an
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increase in sumoylated abducts of Siz1. Given the historic role of ubiquitylation in
protein turnover, as well as the specificity of STUbLs for sumoylated proteins, we
believe that Slx5 mediated ubiquitylation tags Siz1 for degradation. In order to
test this hypothesis we conducted a series of stability assays comparing the halflife of Siz1 from WT and slx5d cells. To our surprise, we were unable to detect a
change in Siz1 turnover when assaying the whole cellular pool of Siz1 (data not
shown).
As discussed previously, Slx5 resides in the nucleus while Siz1
localization is dynamic and cell cycle-dependent. As a result, we reasoned that
Slx5 could be modulating the degradation of a nuclear subpopulation of Siz1 that
is not detectable when immune-blotting the whole cellular pool of Siz1.
Therefore, we have devised a strategy that examines the interaction between
Slx5 and nuclear Siz1. By mutating MSN5 we were able to block the nuclear
egress of Siz1 during mitosis thereby enriching nuclear targets of Slx5. Using this
model, we first observed GFP-tagged Siz1 in wild type cells and compared it to
slx5A, msn5A and the msn5Aslx5A double mutant in logarithmically growing and
G2/M-arrested cells. Consistent with previous results (Makhnevych etal., 2007),
Siz1 -GFP resides in the nucleus for most of the cell cycle, but re-localizes to the
septin ring during mitosis (Figure 4A). However, in both the msn5A and the
msn5Aslx5A double mutant, Siz1 was retained in the nucleus during mitosis and
could not be detected at the septin ring (Figure 4A).
Next we investigated the effect of Msn5 on the steady state level and
phosphorylation state of Siz1. We compared a 4 mutant panel of WT, slx5A,
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msn5A and msn5Aslx5A strains expressing Myc-tagged Siz1 in logarithmic
growth and G2/M arrest. In comparison to WT, no reduction in steady state level
of Siz1 was detected in msn5A cells; however, we did observe an increase in
steady state from logarithmically growing slx5A cells consistent with figure 3. The
phosphorylation state of Siz1 was dramatically influenced by SLX5, MSN5, and
cell cycle stage (Figure 5). In comparison to WT, mutating msn5A reduced the
phosphorylation state and abolished the doubly phosphorylated adduct of Siz1
running at the highest molecular weight. In contrast, mutating slx5A in both the
single and double mutants increases the level of Siz1 phosphorylation. Similar to
Figure 3, G2/M arrest equalizes phosphorylation state and levels of Siz1 in WT,
slx5A and msn5Aslx5A strains. Intriguingly, the phosphorylation of Siz1 from
msn5A cells remains reduced during mitosis arrest implying that some degree of
Siz1 phosphorylation is linked to nuclear export.
In order to demonstrate that nuclear accumulation of Siz1 leads to its
degradation, we performed a cycloheximide chase of Siz1 in mitotically arrested
WT and msn5A cells (Parsupala, N., 2013; Figure 4B). As predicted, we found
that the half-life of Siz1 was dramatically reduced in the msn5A strain. In
comparison, Siz1 was only slightly modulated in the WT strain. Finally, to show
that Slx5 contributes to Siz1 stability, we performed a cycloheximide chase of
nuclear retained Siz1 in msn5A and msn5Aslx5A strains (Figure 4C). Consistent
with our prediction, Siz1 was stabilized in the slx5Amsn5A double mutant, but
degraded rapidly in the msn5A mutant. Furthermore, sumoylated adducts of Siz1
accumulated in the double mutant, while all forms of Siz1 were unstable in the

34

msn5A mutant. This effect was specific to Siz1 retained in the nucleus during
mitosis as a similar experiment conducted in S-phase arrest showed no change
in Siz1 stability or sumoylation (Figure 6).
In conclusion, our data reveals for the first time the functional interplay
between SUMO E3 ligases and SUMO-targeted ubiquitin ligases and
demonstrates that at least three post-translational modifications
(phosphorylation, sumoylation, and ubiquitylation) are involved in this process.
This Slx5-dependent regulation of nuclear localized Siz1 may work in
cooperation with other pathways to prevent the accumulation of specific nuclear
SUMO conjugates that interfere with cell cycle progression or other vital
processes (Figure 4D).

Discussion
In this chapter we present new data on the regulation of the E3 SUMO
ligase Siz1 by the SUMO-targeted ubiquitin ligase Slx5. Siz1 resides in the
nucleus throughout interphase, but becomes phosphorylated in G2/M concurrent
with its nuclear export (Johnson and Gupta, 2001). Recent work by Makhnevych
et al, (2007) has shown that Siz1 is exported from the nucleus by the karyopherin
Msn5 during mitosis where it enriches at the bud neck and participates in septin
sumoylation. In addition to mitotic phosphorylation, Siz1 is modified by SUMO
chains in vivo (Takahashi and Kikuchi, 2005). Previous studies in our lab have
identified a physical interaction between sumoylated Siz1 and Slx5 as well as
identified Siz1 as a STUbL substrate in vivo (Westerbeck et al., 2013). Building
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upon this work, this chapter explores the functional role of Slx5 mediated
ubiquitylation and sheds light on the fate of nuclear Siz1 during mitosis. Our data
raises the possibility of tripartite regulation of Siz1 involving phosphorylation,
sumoylation, and Slx5-mediated ubiquitylation. Specifically, I found that both
phosphorylated and sumoylated Siz1 accumulate in slx5A mutant cells (Figures 3
and 5). When Siz1 is retained in the nucleus of an msn5A mutant,
phosphorylated and sumoylated species are rapidly degraded (Figure 4B). In an
msn5Aslx5A double mutant, however, phosphorylated and sumoylated Siz1 are
stabilized in G2/M, suggesting that STUbLs play a role in modulating SUMO E3
ligases in the nucleus (Figure 4C)
The cross-talk between phosphorylation and sumoylation is poorly
understood; however, a link between sumoylation and phosphorylation has
previously been established. The Siz1 ortholog PIAS1 contains a phosphoregulated SIM which is required to modulate its interactions with specific
transcription factors (Stehmeier and Muller, 2009). Siz1 contains a bona fide
SIM but we have not determined whether it constitutes a phospho-regulated SIM
(Uzunova et al., 2007). It would be beneficial to determine how phosphorylation
and sumoylation work together in governing Siz1 interactions, but our current
understanding of Siz1 phosphorylation is in its infancy and many aspects of Siz1
modification remain unclear. Future research in the lab will identify both the
modifying kinase and phosphorylation sites in order to expand upon research
initiated with this chapter and further characterize the complex cross-talk of
modifications that regulate Siz1.
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In addition to describing the interplay between phosphorylation,
sumoylation, and STUbL mediated ubiquitylation, this work begins to decode the
link between Siz1 phosphorylation and its nuclear shuttling. Msn5 is known to
export phosphorylated cargoes, but it is currently unknown whether or not Siz1
export depends upon phosphorylation (Takahashi e t a i , 2008; Makhnevych et
al., 2007). Our data shows that Msn5 can itself influence phosphorylation of Siz1.
Specifically, mutating Msn5 abolishes a slow moving phosphorylated adduct we
believe to be a doubly phosphorylated species of Siz1 (Figure 5). From this
preliminary data, we could speculate that a phosphorylation event regulated by
Msn5 facilitates Siz1 export during mitosis. Alternatively, this second phosphate
addition could be acquired in the cytosol after export and influence Siz1
interactions with septin proteins. Further work in this direction will explore the
timing and regulation of Sizt nuclear shuttling in order to further our
understanding of cytoplasmic sumoylation.
In conclusion, our data describes the first account of functional interaction
between SUMO ligases and SUMO-targeted ubiquitin ligases. We believe that
the cell cycle-specific degradation of Siz1 by Slx5/Slx8 plays an important
physiological role in reducing nuclear SUMO E3 ligase activity as the cell enters
mitosis. This process likely works in conjunction with the nuclear export pathway
of Siz1 and may prevent the accumulation of nuclear SUMO conjugates that
interfere with cell cycle progression. Considering that Slx5 and Siz1 are
evolutionarily conserved proteins, we predict that the STUbL-mediated regulation
of SUMO-E3 ligases extends to RNF4 and PIAS proteins in mammalian cells. It

37

will be interesting to determine whether RNF4 affects the turn-over of
phosphorylated and sumoylated PIAS1 in mammalian cells. This would further
support the emerging theme of a cross-talk between phosphorylation,
sumoylation, and ubiquitylation in SUMO-targeted degradation.
STUbL regulation of sumoylation pathway likely extends far beyond Siz1.
Recent work by Albuquerque et al. (2013) shows an antagonistic interaction
between Slx5 and the SUMO E3 ligase Mms21. Using quantitative mass
spectrometry they assessed the abundance of sumoylated proteins in a wild-type
strain in comparison to slx5A mutant strain. They found that deleting SLX5
increased the abundance of most sumoylated proteins, with Mms21 -specific
targets being substantially elevated. It would be interesting to determine if Slx5
influences the degradation of Mms21 in a manner similar to Siz1. The
antagonistic relationship between Slx5 and Mms21 fits with our finding and
supports a role for STUbLs in regulating cellular SUMO homeostasis.
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Figure 3. Slx5 affects the steady-state level and phosphorylation
status of Sizl. (A) Altered steady-state level of Sizl in slx5A cells. A
heterozygous diploid SLX5/slx5A SIZ1/SIZ1-myc/HIS3 strain was
sporulated and the resulting haploid progeny of two tetrads (tetrad 7 (YOK
2279-2282) and tetrad 10 (YOK 2283-2286) were genotyped (WT and A).
Proteins were extracted from the indicated haploid strains to determine the
steady-state levels of the myc-tagged S izl protein in WT and slx5A
progeny. An anti- myc antibody was used to detect Sizl on immunoblots of
SDS-PAGE separated proteins. Note the increased steady-state levels and
modifications of Sizl in slx5A strains (tetrad 7-4 and tetrad 10-3) in
comparison to Sizl levels in SLX5 WT strains (tetrad 7-1 and tetrad 10-4).
Equal protein loading was confirmed by immunoblot for the housekeeping
protein 3-phosphoglycerate kinase (PGK1). (B) Sizl is differentially
phosphorylated under various growth conditions in WT (YOK 2286) versus
slx5A (YOK 2264) cells. Log: untreated, logarithmically growing cells; HU:
hydroxyurea treatment to arrest in S-phase; NZ: nocodazole treatment to
arrest in G2/M. Endogenous, myc-tagged Sizl protein in W T and slx5A
cells was detected after immunoblotting of SDS-PAGE separated proteins
using an anti-myc antibody. (* and **) denotes differentially phosphorylated
forms of S iz l.
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Figure 4. Slx5 modulates the levels of Siz1 in the nucleus. (A) WT
(YOK2738), slx5A (YOK2751), msn5A (YOK2624), and msn5Aslx5A
(YOK2735) strains expressing Siz1- GFP as the only copy of this SUMO
ligase were imaged during logarithmic growth (log - left panel) or after
nocodazole induced G2/M arrest (Noc - right panel). The localization of
Siz1-GFP at septins is indicated with yellow arrows and the localization of
nuclei in msn5A and msn5Aslx5A strains is indicated with white arrow
heads. (B) Siz1 is rapidly degraded in an msn5A mutant: Isogenic WT
(YOK 2397) and msn5A (YOK 2514) strains expressing endogenous fulllength Siz1-myc were grown overnight in YPD medium. Cells in
logarithmically grown cultures were arrested with nocodazole. 10 ODs of
G2/M-arrested cells were pelleted, washed and resuspended in fresh YPD
medium without nocodazole containing 25 pg/ml of cycloheximide.
Subsequently, protein extracts of 2.5 ODs of cells were prepared at the
indicated time points (0, 10, 30, 60 min) prior to western blotting to detect
Siz1-myc. (C) A deletion of SLX5 stabilizes Siz1 in an msnSA mutant:
Isogenic msn5A and msn5Aslx5A strains expressing Siz1-myc from
LEU2/CEN plasmid pRS315 were grown overnight in selective media. Cells
in logarithmically grown cultures were arrested with nocodazole and
benomyl. 22 ODs of G2/M-arrested cells were pelleted, washed and
resuspended in fresh YPD medium without nocodazole containing 25pg/ml
of cycloheximide. Subsequently, protein extracts of 2 ODs of cells were
prepared at the indicated time points (0, 40, 60, 90, 120 minutes) prior to
western blotting to detect Siz1-myc and Pgk1 proteins. The first two lanes,
msn5A (log) and msn5Aslx5A (log), are overloaded to show SUMO adducts
of Siz1 in these strains. (D) Model of a STUbL-dependent nuclear
degradation pathway of sumoylated Siz1: At the onset of mitosis nuclear
Siz1 becomes auto-sumoylated (green circles) and phosphorylated (p) via
an unknown kinase. Phosphorylated Siz1 is then subject to Msn5mediated nuclear export to facilitate septin sumoylation in the cytosol.
Sumoylated Siz1 that remains in the nucleus as the cell enters mitosis (in
our experiments this was accomplished through deletion of MSN5) is
subject to STUbL- mediated ubiquitylation (circle labeled Ub) and
degradation. Other non-STUbL- dependent pathways for the regulation of
Siz1 activity and levels may exist.
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S iz i-P --------Siz1

Figure 5. Slx5, Msn5 and cell cycle stage affect the phosphorylation
state o f Siz1. Strains 2397 (WT) 2396 (s/x5A) 2514 (msn5A) and
25'\3{slx5A/msn5A) expressing endogenous Siz1-Myc were grown up
overnight in YPD. Proteins were extracted from 4 ODs of Log and G2/M
arrested cells.
Phosphorylation state of SizlM yc from treated and
untreated cells was detected on immunoblots of SDS-PAGE separated
proteins. Two levels of phosphorylation as well as unmodified Siz1 were
detected. (Siz1-P and P-Siz1-P) denote the two phosphorylation states of
Siz1. Siz1 phosphorylation is decreased in msn5A versus WT cells, but
increased when SLX5 is also deleted. Siz1 is differentially phosphorylated
in WT versus s/x5A cells and overall phosphorylation increases during
G2/M arrest confirming the findings from Figure 8B. Log: untreated,
logarithmically growing cells; Nocodazole: cells treated with 25 pg/mL
nocodazole to arrest in G2/M; WT: Wild type; A/A: s/x5A and msn5A strain
YOK 2513

43

Background
MPT —

0m

msn5A
30m

... - “jB prr

m nm mmm

60m

inlriMl—T^liinir

msn5Vslx5A
90m

120m

0m

30m

^
"■'■W
ttSSSt'!'
— (■MMfc

—

60m

90m

WT
120m

•*r>aMei.viy:
MMMM

0m

120m

JU H H H k v flH H tr

SizlMyc
SUMO"

V

- SizlMyt

Figure 6. Cyclohexim ide chase o f S-Phase arrested cells. Strains YOK
2757 (WT), 2759 (msn5A), and 2761 (slx5A/msn5A) expressing SizlM yc from
a LEU2/CEN plasmid pRS315 were grown overnight in selective media to log
phase. Cultures that had not reached stationary phase after overnight growth
were arrested in S-phase with 0.1M hydroxyurea.
22 ODs of S-phase
arrested cells were pelleted, washed and resuspended in fresh YPD medium
without hydroxyurea containing 25pg/ml of cycloheximide. Subsequently,
protein extracts of 2 ODs of cells were prepared at the indicated time points (0,
30, 60, 90, 120 minutes) prior to western blotting to detect Siz1-myc. MPT;
Minutes post-treatment with cycloheximide; WT: Wild type; -Siz1 denotes
unmodified Siz1 and SizlM yc SUMOn denotes sumoylated forms of Siz1.

44

Appendix
PCR-based gene modification; Mvc tagging Siz1 (Modified from Lonqtine et a!.,
1998)
Primes OOK662 and 663 (table 5) were used to PCR amplify 13xmyc-ADH1His3MX6 cassette with 40bp of SIZ1 sequence homology from the plasmid
pFA6a-13myc-His3MX6. Primer overhangs are homologous to 40 bases
upstream of SIZ1 stop codon and 40 bases downstream from SIZ1 stop codon,
but do not include the stop codon itself. 8x 50pL PCR reactions were pooled and
extracted with phenol/chloroform/isoamyalcohol. The aqueous extract was
ethanol precipitated and resuspended in 25ul of 1x Tris-EDTA (TE) by vortexing
and pipetting. Transformation mixture was made by combining the 12.5ul of pure
PCR product with 160ul of sterile 50% glycerol, 20ul of 10X TE, 20ul of 1M
lithium acetate and 5 ul of denature herring sperm DNA (ssDNA).
5mL of YOK 821 (s/x5A) was grown overnight in YPD. In the morning, the
stationary culture was diluted to OD6oo of 0.3 and allowed to grow for 2
generations. 10D of the recovered culture was harvested and suspended in
100mM lithium acetate + 1X TE then incubated at 30°C for 30 minutes.
After incubating for 30 minutes, the cells were collected by brief (5
second) centrifugation and gently resuspended in the transformation mixture
from above. Cells in transformation mixture were incubated at 30°C for an
additional 30 minutes before heatshocking at 42°C for 40 minutes. A long heat
(30-40 minutes) is critical for successful transformation. After heat shocking, the
cells were collected by brief centrifugation and washed once in pre-warmed 2x
YEP and resuspended in pre-warmed 2x YPD. The cells were then incubated at
30°C, spinning for 1 hour and plated on a single selective plate. Transformant
colonies were visible after 3 days.
Additional notes; Incubating cells overnight in 100mM lithium acetate + 1X
TE before transformation increases efficiency. We have also had success with
overnight recoveries in YPD after transformation and overnight growth in liquid
selective media.
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Preparation of high cell density yeast ‘noodles’ and cryogenic cell lysis.
A single colony was grown overnight in 40mL of selective media
containing 2% dextrose. The next day, the 40mL starter culture was added to two
liters of selective media containing 2% dextrose and split into four 1L flasks to
allow for sufficient aeration. The two liter culture was grown to late log phase
and the whole culture was harvested by centrifugation at 4,000 x gravity in the
cold. The resulting cell pellet was washed first in 50mL wash buffer (table 2) and
then in 10mL of extrusion buffer (table 2). Residual buffer was removed by
m icro pi petto r and the cell paste was scooped into a 10mL syringe with a sterile
spatula. The cells were then extruded from the syringe into a 50mL centrifuge
containing liquid nitrogen and snap-frozen as high density ‘noodles’ of cells. The
centrifuge tube containing noodles and residual liquid nitrogen was placed at 80°C with holes punched in the cap to allow the nitrogen to vaporize.
Yeast noodles were lysed using a cryogenic tissue grinder (coffee grinder)
to break open the cells. To do this, dry ice was powdered in a pre-chilled (-20°C)
grinder. The amount of dry ice powder used is arbitrary, but was enough to take
up about half the volume of the grinder and completely cover the yeast noodles
when they are added. Yeast noodles were taken from the -80°C freezer and
immediately placed into the dry ice. Cells were lysed by grinding for 5 minutes on
the espresso setting at -20°C. The resulting powder of pulverized yeast cells and
dry ice was placed at -80°C in a 50mL centrifuge tube with the top loose to allow
the dry ice to sublimate. The powdered yeast cells were thawed on ice and
resuspended in extraction buffer (table 2).
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Supplemental Figure 1. Diagram of methodology used for U-Tag affinity
purification.
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Table 1. Strains and plasmids
Name
MHY500
(YOK819)

MHY501
(YOK820)

Plasmids
or construction

Pertinent
Genotypes

Reference

Li and Hochstrasser,
2003

Mata his3-A200 leu2-3,
112 ura3- 52lys2801trp1-1gal2

Mata his3-A200 leu2-3,
112 ura3- 52lys2801trp1-1
gal2

BY4741
(YOK1322)

MATa leu2A0 m e tl5 A 0
ura3A0

Brachmann et
al., 1998

JD52
(YOK2062)

MATa ura3-52 his3A200 Ieu2- 3,112
trn1-A83 lvs?-RD1
ulp1::K
an MX;
u lp lts

Dohmen et al., 1995

YOK428

YOK2396

GPD-Smt3gg-LEU2

slx5::KanMX4 s iz l13xmyc/HIS5

YOK 2373
This study
transformed with s iz lmyc/HIS5

YOK2397

JD52 Siz1-13xmyc:HIS5 YOK 2062 (JD52)
This study
transformed with s iz lmyc/HIS5

YOK2514

msn5::HYGSiz113xmyc:HIS5 (based
on YOK 2397)

YOK 2397
transformed with
msn5::hygro

This study

YOK2513

msn5::HYG,
slx5::KanMX4 Siz113xmyc:HIS5

YOK 2396
transformed with
msn5::hygro

This study

YOK3712
(MHY821)

slx5::KanMX4

YOK2264

six 5A Siz113xmyc:HIS5

MHY821 transformed
with siz1-myc/HIS5

YOK2286

Siz 1-13xmyc:HIS5

YOK2738

JD52 Siz1-GFP/HIS5

MHY501 transformed
with siz1-myc/HIS5
YOK 2062 (JD52)
transformed with Siz1GFP/HIS5
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Xie et al.,
2007
This study
This study
This study

Name

Pertinent
Genotypes

Plasmids
or construction

Reference

YOK2751

JD52 slx5::KanMX4
Siz1GFP/HIS5

YOK 2373 (JD52)
transformed with Siz1GFP/HIS5

This study

YOK2624

JD52 msn5::HYG Siz1- YOK2505 (JD52)
GFP/HIS5
transformed with Siz1GFP/HIS5

This study

YOK2735

JD52 slx5::KanMX4
msn5::HYG
Siz1-GFP/HIS5

YOK2681 (JD52)
transformed with Siz1GFP/HIS5

This study

YOK2757

JD52

Siz1 -13xmyc/LEU2
on pRS315 (BOK982)

This study

YOK2758

JD52 slx5::KanMX4

Siz1 -13xmyc/LEU2
on pRS315 (BOK982)

This study

YOK2759

JD52 msn5::HYG

Siz1-13xmyc/LEU2
on pRS315 (BOK982)

This study

YOK2761

JD52 slx5::KanMX4
msn5::HYG

Siz1-13xmyc/LEU2
on pRS315 (BOK982)

This study

BOK752

Elmore et al., 2011

*R + pMALUlp1(lll)C580S

49

Table 2. Buffers used in Chapter 2.

Buffer

Components

Wash
buffer

50mM HEPES
3m M DTT
2% Dextrose

Chapter and
relevant reference
Chapter 2; From
Dr. Kamakaka,
Rohinton T.
Personal
commmunication

Extrusion

50mM HEPES pH 7.8
150mM NaCI
1mM EDTA
14mM 2mercaptoethanol
5mM MgCI2

Chapter 2; From
Dr. Kamakaka,
Rohinton T.
Personal
commmunication

Extraction

50mM HEPES pH 7.8
325mM NaCI
14mM 2mercaptoethanol
5mM MgCI2
10% glycerol

Protease Inhibitors
added

Halts inhibitor cocktail
(Sigma)
Halts inhibitor cocktail
(sigma) to 1x
4mM Benzamidine
50pM TPCK
5-pM TLCK
1mM PMSF
10mM NEM
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Chapter 2; From
Dr. Kamakaka,
Rohinton T.
Personal
commmunication

Table 3. Raw data from MudPIT analysis of U-Tag affinity purified proteins.
Parentheses represent gene names from Saccharomyces Genome Database
(yeastgenome.org)
R eten tion
P eptide sequence

R ete n tio n Tim e
M ean

T im e l

Pep
S c o re l

P ro tein ID1

IDPSSDIANLK

33.55

33.55

32.6

ABP1_YEAST

SISIVGSYVGNR

36.55

36.55

32.86

ADH1_YEAST

YLAEFSSGDAR

29.9167

29.9167

31.73

BMH1_YEAST

IVSSIEQK

17.7333

17.7333

38.93

BMH1_YEAST

ATNASLEAYK

22.1333

22.1333

38.18

BMH1_YEAST

DSTLIMQLLR

56.1833

56.1833

30.31

BMH1_YEAST

YEEMVENMK

26.2833

26.2833

31.58

BMH1_YEAST

30.1167

30.1167

24.97

CSM3_YEAST

26.95

26.95

45.83

EF1A_YEAST

37.2333

37.2333

31.18

EF1A_YEAST

IRISSKK(SUM03_yeast_Try
psin (K))
QTVAVGVIK
YAWVLDK

EF2_YEAST
STLTDSLVQR

31.1667

31.1667

31.37

(EFT2)

26.95

26.95

34.39

(EFT2)

33.8333

33.8333

33.01

(EFT2)

EF2_YEAST
AGEIVLAAR

EF2_YEAST
VAFTVDQMR

EF2_YEAST
(EFT2)

ISPPVVAYR

32.1833

32.1833

42.05

IGLDC(cam)ASSEFFK

44.5167

44.5167

39.81

EN01_YEAST

40.4333

40.4333

35.52

EN01_YEAST

25.65

25.65

68.88

G3P3_YEAST

NGHWALDYTISR

37.8833

37.8833

47.91

GDE_YEAST

EANAGPNLDR

16.8667

16.8667

67.52

GDE_YEAST

50.5

50.5

48.81

GYS2_YEAST

26.15

26.15

55.72

GYS2_YEAST

EAQVDIEAIK

31.9333

31.9333

31.85

HS104_YEAST

ELQDIANPIMSK

38.6833

38.6833

57.18

HSP71_YEAST

33.25

33.25

27.99

HSP75_YEAST

ELISNASDALDK

32.2833

32.2833

45.77

HSP82_YEAST

EILGDQVEK

24.7667

24.7667

33.33

HSP82_YEAST

NIYYITGESLK

38.3333

38.3333

36.97

HSP82_YEAST

32.6

32.6

29.04

HSP82_YEAST

36.7833

36.7833

39.35

KPYK1_YEAST

IEEELGDNAVFAGENFHHGD
KL
TASGNIIPSSTGAAK

VILFDLDSVR
APITVAQYK

M(ox)KEIAEAK

LLDAPAAIR
YRPNC(cam)PIILVTR
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R eten tion
P eptide sequence

R eten tion Tim e

T im e l

M ean

Pep
S c o re l

P ro tein ID1
(CDC19)
KPYK1_YEAST

TSIIGTIGPK

34.5167

34.5167

44.04

(CDC19)
KPYK1_YEAST

IMYVDYK

30.4667

30.4667

30.08

37.4167

37.4167

49.33

36.25

36.25

43.81

(CDC19)

RKEDDGDGVAWDSEQYTVP
EVQR

LEU3_YEAST
PHSG_YEAST

VVFVADYNVSK

(GPH1)
PHSG_YEAST

RLTpGFLPQEIK

42.5833

42.5833

52.39

(GPH1)
PHSG_YEAST

FIDHVETTLAR

31.5833

31.5833

43.6

VLYVGNLDK

33.2333

33.2333

29.61

PUB1_YEAST

HSGNIQLDEIIEIAR

48.9667

48.9667

34.13

RL12A_YEAST

EILGTAQSVGC(cam)R

27.5833

27.5833

49.43

RL12A_YEAST

33

33

37.9

(RPPO)

25.4667

25.4667

29.11

(RPPO)

(GPH1)

RLA0_YEAST
GTIEIVSDVK

RLA0_YEAST
EYLEEYK

RLA0_YEAST
SLFVVGVDNVSSQQMHEVR

42.35

88.65

31.1

31.1

52.22

RLA4_YEAST

KVVGASVVVVK

26.3667

26.3667

20.5

RS12_YEAST

LVEGLANDPENKVPLIK

40.1333

40.1333

24.24

RS12_YEAST

AVVESVGAEVDEAR

42.35

(RPPO)

LAVLSYYK

36.6833

36.6833

26.81

RS27A_YEAST

RPASSpDSLLK

38.4833

38.4833

34.82

SAS4_YEAST

FLYDGIR

34.0333

34.0333

31.36

SMT3_YEAST

21.25

21.25

27.49

SMT3_YEAST

LM(ox)EAFAK
IQADQTPEDLDMEDNDIIEA
HR

39.85

39.85

60.84

SMT3_YEAST

HEEALEVDSLIK

33.7667

33.7667

30.88

STE23_YEAST

LDVDELGDVAQ.K

37.1333

37.1333

49.47

TRX1_YEAST

SASEYDSALASGDK

24.1833

24.1833

70.92

TRX2_YEAST

LDVDEVSDVAQK

32.5667

32.5667

56.23

TRX2_YEAST

17.85

17.85

57.56

ULP1_YEAST

STPNTVAFNSFFYTNLSER

51.9167

51.9167

41.52

ULP1_YEAST

RWLNDTIIEFFMK

62.6833

62.6833

37.88

ULP1_YEAST

ENTQLMNR

TQIDKLDK

16.35

16.35

58.33

ULP1_YEAST

70.6667

70.6667

36.43

ULP1_YEAST

DNIEITVR

34.6

34.6

67.01

ULP1_YEAST

YVMEESK

15.05

15.05

36.44

ULP1_YEAST

48.5333

48.5333

62.91

ULP1 YEAST

WLNDTIIEFFMK

FIAHLILTDALK
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R ete n tio n
Peptide sequence

T im e l

YVM(ox)EESK
ENTQLM(ox)NR

R eten tion Tim e
M ean

Pep
S c o re l

P ro tein ID1

11.25

11.25

35.12

ULP1_YEAST

13.6833

13.6833

54.67

ULP1_YEAST

40.55

40.55

40.12

VATE_YEAST
LLSEEALPAIR

(VM A4)
VATE_YEAST

EQSLDGIFEETK

40.5

40.5

47.89

(VM A4)

2 1.3167

21.3167

50.76

(VM A4)

SNPPQVPSGWK

30.15

30.15

34.15

W W M 1_YEAST

IVLSpFFLR

40.55

40.55

34.36

YD159_YEAST

25.9

25.9

45.4

YP13B_YEAST

VATE_YEAST
ADQEYEIEK

EVHTNQDPLDVSASK

Table 4. Selected results from MudPIT analysis o f U-Tag affin ity purified
proteins. Full results from the mass spectrometry analysis are in table 3.
Sequence

Gene Name

Fragment

Description

YLA EFSSG D A R

BM H1

-1

1 4 -3 -3

IV S S IE Q K

BM H1

-2

A TN A S L E A Y K

BM H1

-3

Acidic, Dimeric
Role in signal transduction

D S T L IM Q L L R

BM H1

-4

Y E E M V E N M K

BM H1

-5

S TLTD SLVQ R

EF2

-1

A G E IV L A A R

EF2

-2

V A F T V D Q M R

EF2

-3

IS P P V V A Y R

EF2

Elongation factor 2

-4

F L Y D G IR

SU M O

-1

L M (o x )E A F A K

SU M O

-2

IQ A D Q T P E D L D M E D N D IIE A H R

SU M O

E Q S L D G IF E E T K

V M A 4

-1

A D Q E Y E IE K

V M A 4

-2

L L S E E A L P A IR

V M A 4

SUMO

-3

-3
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Peripheral membrane
domain o f the vacuolar
ATPase

Table 5. Primers used in PCR-based Myc tagging of SIZ1. Red letters
represent SIZ1 sequence homology.
Primer
OOK662
OOK663

Sequence
5’AGAGCTGGACGGAACCGTCCAATTTTAGCCTCGTTTTTAGAATTCGAGCTCGTTTAAAC3’
5’ATGGAAAACGCAAGATTATGGAAAGAAATACAACAGTGGTCGGATCCCCGGGTTAATTA
A-3’

References:

Alonso, A., D'Silva, S., Rahman, M., Meluh, P. B., Keeling, J., Meednu, N.,
Hoops, H. J., and Miller, R. K. (2012). The yeast homologue of the microtubuleassociated protein Lis1 interacts with the sumoylation machinery and a SUMOtargeted ubiquitin ligase. Mol. Biol. Cell 23, 4552-4566.

Amberg, D.C., Burke, D.J. & Strathern, J.N., (2005). Methods in Yeast
Genetics;A Cold Spring Harbor Laboratory Course Manual 2005th ed., cold
spring harbors press.

Baba, D., Maita, N., Jee, J.-G., Uchimura, Y., Saitoh, H., Sugasawa, K.,
Hanaoka, F., et al. (2005). Crystal structure of thymine DNA glycosylase
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